| Batch 1 (N = 132) | Batch 2 (N = 296) | Total (N = 428) |
---|---|---|---|
EOC status | Â | Â | Â |
  Control | 66 (50.0%) | 148 (50.0%) | 214 (50.0%) |
  Case | 66 (50.0%) | 148 (50.0%) | 214 (50.0%) |
Age | Â | Â | Â |
  Mean (SD) | 60 (12) | 63 (13) | 62 (13) |
  Median | 61 | 65 | 64 |
  Q1, Q3 | 50, 69 | 54, 73 | 52, 72 |
  Range | (33–82) | (27–91) | (27–91) |
Year enrolled | Â | Â | Â |
  1999–2002 | 18 (13.6%) | 164 (55.4%) | 182 (42.5%) |
  2003 | 10 (7.6%) | 36 (12.2%) | 46 (10.7%) |
  2004 | 41 (31.1%) | 33 (11.1%) | 74 (17.3%) |
  2005 | 25 (18.9%) | 23 (7.8%) | 48 (11.2%) |
  2006–2007 | 38 (28.8%) | 40 (13.5%) | 78 (18.2%) |
Parity, number of births | Â | Â | Â |
  Nulliparous | 24 (18.2%) | 42 (14.2%) | 66 (15.4%) |
  1-2,<=20 yrs | 7 (5.3%) | 14 (4.7%) | 21 (4.9%) |
  1-2,>20 yrs | 31 (23.5%) | 84 (28.4%) | 115 (26.9%) |
  3+,<=20 yrs | 28 (21.2%) | 47 (15.9%) | 75 (17.5%) |
  3+,>20 yrs | 40 (30.3%) | 95 (32.1%) | 135 (31.5%) |
Smoking status (current) | Â | Â | Â |
  No | 120 (90.9%) | 259 (87.5%) | 379 (88.6%) |
  Yes | 10 (7.6%) | 19 (6.4%) | 29 (6.8%) |
State | Â | Â | Â |
  Other | 68 (51.5%) | 120 (40.5%) | 188 (43.9%) |
  Minnesota | 64 (48.5%) | 176 (59.5%) | 240 (56.1%) |
Alcohol consumption | Â | Â | Â |
  Never | 32 (24.2%) | 71 (24.0%) | 103 (24.1%) |
  Current | 78 (59.1%) | 152 (51.4%) | 230 (53.7%) |
  Former | 18 (13.6%) | 47 (15.9%) | 65 (15.2%) |
Histology | Â | Â | Â |
  Serous | 43 (65.2%) | 98 (66.2%) | 141 (65.9%) |
  Mucinous | 1 (1.5%) | 4 (2.7%) | 5 (2.3%) |
  Endometrioid | 16 (24.2%) | 33 (22.3%) | 49 (22.9%) |
  Clear Cell | 4 (6.1%) | 9 (6.1%) | 13 (6.1%) |
  Other | 2 (3.0%) | 4 (2.7%) | 6 (2.8%) |
Grade | Â | Â | Â |
  Grade 1 | 1 (1.6%) | 9 (6.1%) | 10 (4.7%) |
  Grade 2 | 10 (15.6%) | 21 (14.2%) | 31 (14.6%) |
  Grade 3 | 32 (50.0%) | 79 (53.4%) | 111 (52.4%) |
  Grade 4 | 21 (32.8%) | 39 (26.4%) | 60 (28.3%) |
Stage | Â | Â | Â |
  Stage 1 | 11 (16.7%) | 29 (19.6%) | 40 (18.7%) |
  Stage 2 | 3 (4.5%) | 11 (7.4%) | 14 (6.5%) |
  Stage 3 | 43 (65.2%) | 84 (56.8%) | 127 (59.3%) |
  Stage 4 | 9 (13.6%) | 24 (16.2%) | 33 (15.4%) |